Analysis of Key Genes and Pathways Associated with Colorectal Cancer with Microarray Technology |
Liu, Yan-Jun
(Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University)
Zhang, Shu (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University) Hou, Kang (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University) Li, Yun-Tao (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University) Liu, Zhan (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University) Ren, Hai-Liang (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University) Luo, Dan (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University) Li, Shi-Hong (Department of General Surgery, The Third People's Hospital of Chengdu, The Second Clinical College Affiliated to Chongqing Medical University) |
1 | Talseth-Palmer BA, McPhillips M, Groombridge C, et al (2010). MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hered Cancer Clin Pract, 8, 5. DOI ScienceOn |
2 | Todaro M, Francipane MG, Medema JP, Stassi G (2010). Colon cancer stem cells: promise of targeted therapy. Gastroenterology, 138, 2151-62. DOI ScienceOn |
3 | Wood LD, Calhoun ES, Silliman N, et al (2006). Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Hum Mutat, 27, 1060-1. |
4 | Xi HQ, Zhao P (2011). Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol, 64, 498-503. DOI ScienceOn |
5 | Yang WL, Frucht H (2001). Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis, 22, 1379-83. DOI ScienceOn |
6 | Zhai XH, Yu JK, Yang FQ, Zheng S (2012). Identification of a new protein biomarker for colorectal cancer diagnosis. Mol Med Report, 6, 444-8. |
7 | Ager EI, Neo J, Christophi C (2008). The renin-angiotensin system and malignancy. Carcinogenesis, 29, 1675-84. DOI ScienceOn |
8 | Aizat AA, Shahpudin SN, Mustapha MA, et al (2011). Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population. Asian Pac J Cancer Prev, 12, 2909-13. |
9 | Amid A, Wan Chik WD, Jamal P, Hashim YZ (2012). Microarray and quantitative PCR analysis of gene expression profiles in response to treatment with tomato leaf extract in mcf-7 breast cancer cells. Asian Pac J Cancer Prev, 13, 6319-25. 과학기술학회마을 DOI ScienceOn |
10 | Ansel KM, Harris RB, Cyster JG (2002). CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity, 16, 67-76. DOI ScienceOn |
11 | Bernardi CC, Ribeiro Ede S, Cavalli IJ, et al (2010). Amplification and deletion of the ACHE and BCHE cholinesterase genes in sporadic breast cancer. Cancer Genet Cytogenet, 197, 158-65. DOI ScienceOn |
12 | Bigler J, Whitton J, Lampe JW, et al (2001). CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res, 61, 3566-9. |
13 | Brass N, Racz A, Heckel D, et al (1997). Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res, 57, 2290-4. |
14 | Burrell LM, Johnston CI, Tikellis C, Cooper ME (2004). ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab, 15, 166-9. DOI ScienceOn |
15 | Davies H, Hunter C, Smith R, et al (2005). Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res, 65, 7591-5. |
16 | de Wit M, Fijneman RJ, Verheul HM, et al (2012). Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications. Clin Biochem, 46, 466-79. |
17 | Dong P, He XW, Gu J, et al (2011). Vimentin significantly promoted gallbladder carcinoma metastasis. Chin Med J Beijing, 124, 4236. |
18 | Doniger SW, Salomonis N, Dahlquist KD, et al (2003). MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol, 4, R7. DOI |
19 | Draghici S, Khatri P, Tarca AL, et al (2007). A systems biology approach for pathway level analysis. Genome Res, 17, 1537-45. DOI ScienceOn |
20 | Edgar R, Domrachev M, Lash AE (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res, 30, 207-10. DOI ScienceOn |
21 | El-Haibi CP, Singh R, Sharma PK, et al (2011). CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation. Cell Prolif, 44, 311-9. DOI ScienceOn |
22 | Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. DOI ScienceOn |
23 | Garber K (2010). Of Ephs and ephrins: companies target guidance molecules in cancer. J Natl Cancer Inst, 102, 1692-4. DOI ScienceOn |
24 | George AJ, Thomas WG, Hannan RD (2010). The reninangiotensin system and cancer: old dog, new tricks. Nat Rev Cancer, 10, 745-59. DOI ScienceOn |
25 | Greystoke A, Dean E, Saunders MP, et al (2012). Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer. Br J Cancer, 107, 1518-24. DOI ScienceOn |
26 | Hong F, Breitling R, McEntee CW, et al (2006). RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics, 22, 2825-7. DOI ScienceOn |
27 | Hong Y, Ho KS, Eu KW, Cheah PY (2007). A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin Cancer Res, 13, 1107-14. DOI ScienceOn |
28 | Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57. |
29 | Hubner RA, Muir KR, Liu JF, et al (2006). Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clin Cancer Res, 12, 6585-9. DOI ScienceOn |
30 | Hunter S, Apweiler R, Attwood TK, et al (2009). InterPro: the integrative protein signature database. Nucleic Acids Res, 37, D211-5. DOI ScienceOn |
31 | Johnson V, Lipton LR, Cummings C, et al (2005). Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families. J Med Genet, 42, 756-62. DOI ScienceOn |
32 | Koizumi K, Kozawa Y, Ohashi Y, et al (2007). CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncol Rep, 17, 1511-6. |
33 | Lisabeth EM, Fernandez C, Pasquale EB (2012). Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms. Biochemistry, 51, 1464-75. DOI ScienceOn |
34 | Liu N, Fang XD, Vadis Q (2012). CD73 as a novel prognostic biomarker for human colorectal cancer. J Surg Oncol, 106, 918-9; author reply 920. DOI ScienceOn |
35 | Lokshin AE, Winans M, Landsittel D, et al (2006). Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer. Gynecol Oncol, 102, 244-51. DOI ScienceOn |
36 | Marx J (2004). Cancer research. Inflammation and cancer: the link grows stronger. Science, 306, 966-8. DOI ScienceOn |
37 | Meng W, Zhu HH, Xu ZF, et al (2012). Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World J Gastrointest Oncol, 4, 145-51. DOI ScienceOn |
38 | Menin C, Scaini MC, De Salvo GL, et al (2006). Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst, 98, 285-8. DOI ScienceOn |
39 | Montenegro MF, Ruiz-Espejo F, Campoy FJ, et al (2006). Acetyland butyrylcholinesterase activities decrease in human colon adenocarcinoma. J Mol Neurosci, 30, 51-4. DOI ScienceOn |
40 | Pan D, Sun N, Cheung KH, et al (2003). PathMAPA: a tool for displaying gene expression and performing statistical tests on metabolic pathways at multiple levels for Arabidopsis. BMC bioinformatics, 4, 56. DOI ScienceOn |
41 | Panse J, Friedrichs K, Marx A, et al (2008). Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. Br J Cancer, 99, 930-8. DOI ScienceOn |
42 | Pasquale EB (2010). Eph receptors and ephrins in cancer:bidirectional signalling and beyond. Nat Rev Cancer, 10, 165-80. DOI ScienceOn |
43 | Ricci-Vitiani L, Fabrizi E, Palio E, De Maria R (2009). Colon cancer stem cells. J Mol Med (Berl), 87, 1097-104. DOI ScienceOn |
44 | Rubie C, Frick VO, Pfeil S, et al (2007). Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol, 13, 4996-5002. |
45 | Sabates-Bellver J, Van der Flier LG, de Palo M, et al (2007). Transcriptome profile of human colorectal adenomas. Mol Cancer Res, 5, 1263-75. DOI ScienceOn |
46 | Samowitz WS, Wolff RK, Curtin K, et al (2006). Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol, 4, 894-901. DOI ScienceOn |
47 | Shields JD, Kourtis IC, Tomei AA, et al (2010). Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science, 328, 749-52. DOI ScienceOn |
48 | Singh S, Singh R, Sharma PK, et al (2009). Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett, 283, 29-35. DOI ScienceOn |
49 | Smyth GK (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, 3, Article3. |
50 | Surawska H, Ma PC, Salgia R (2004). The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev, 15, 419-33. DOI ScienceOn |
51 | Takahashi M, Cuatrecasas M, Balaguer F, et al (2012). The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One, 7, e46684. DOI |
52 | Takahashi N, Goto T, Kusudo T, et al (2005). [The structures and functions of peroxisome proliferator-activated receptors (PPARs)]. Nihon Rinsho, 63, 557-64. |